VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
216 hedge funds and large institutions have $1.35B invested in Meridian Bioscience Inc in 2022 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 67 increasing their positions, 73 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 210 → 216 (+6)
8% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 73
Holders
216
Holding in Top 10
5
Calls
$5.9M
Puts
$1.05M
Top Buyers
| 1 | +$40.7M | |
| 2 | +$14.7M | |
| 3 | +$5.99M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$5.5M |
| 5 |
Neuberger Berman Group
New York
|
+$4.26M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$10.3M | |
| 3 | -$6.59M | |
| 4 |
VLKIM
Van Lanschot Kempen Investment Management
Amsterdam,
Netherlands
|
-$6.42M |
| 5 |
BlackRock
New York
|
-$4.41M |